Development of Biocatalysts for Chemodivergent Functionalizations of Heterocycles

杂环化合物化学趋异功能化生物催化剂的开发

• 批准号: 10464580
• 负责人: Jennifer L. Kennemur
• 金额: $ 6.68万
• 依托单位: CALIFORNIA INSTITUTE OF TECHNOLOGY
• 依托单位国家: 美国
• 财政年份: 2022
• 资助国家: 美国
• 起止时间: 2022-04-10 至 2025-04-09
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10464580
• 关键词: Acetals; Alkenes; Catalysis; Chemicals; Complex; Cytochrome P450; Development; Directed Molecular Evolution; Engineering; Enzymes; Event; Evolution; Exhibits; Goals; Heavy Metals; Heme; Heme Iron; Hemeproteins; Hydrogen Bonding; In Situ; Indoles; Laboratories; Libraries; Metals; Methodology; Methods; Modeling; Molecular; Nature; Outcome; Pharmaceutical Preparations; Pharmacologic Substance; Pharmacology; Process; Production; Property; Proteins; Pyrroles; Reaction; Research; Research Proposals; Role; Route; System; Testing; Therapeutic; Transition Elements; Variant; Walking; Work; carbene; catalyst; chemical reaction; cost; cyclopropane; drug discovery; improved; metal complex; mutant; novel therapeutics; programs; pyridine; research and development; scaffold; small molecule; tool

PROJECT SUMMARY/ABSTRACT Methodological advances that allow for rapid and efficient access to a wide range of functionalized heterocycles are imperative for streamlining drug discovery processes. Given the vast ubiquity of heterocycles in bioactive compounds, the functionalization of existing heterocycles is a common strategy used to tune important pharmacological properties of drugs. Cyclopropanations of heterocycles represent a particularly attractive strategy to achieve synthetic diversification, as the corresponding fused bicyclic frameworks are not only present in bioactive small molecules, but are key chemical synthons en route to more complex scaffolds. The resultant motifs are classified as donor-acceptor cyclopropanes (or push-pull cyclopropanes) and exhibit unique proclivities toward cyclopropane ring opening and subsequent reactivity. Transition metal complexes have been used to access these important synthetic frameworks through metal-carbenoid cyclopropanation reactions, however many of these strategies suffer from low levels of chemo and/or stereoselectivity or depend on a specific class of carbene precursor to achieve high selectivity. Alternatively, enzymes can impart exquisite chemo-, regio-, and stereoselectivities in reactions that are challenging in small molecule catalysis. Directed evolution has provided a powerful platform by which Nature’s enzymes can be repurposed to develop new-to- nature chemical transformations, including engineered P450 enzymes capable of olefin cyclopropanation and C‒H functionalization. The focus of this proposal is to expand the breadth of activity of engineered iron-heme carbenes to include cyclopropanations of heterocycles and to investigate their capacity to elicit cascade reactions on the corresponding cyclopropanes. The specific aims are (1) to evolve hemoprotein variants capable of catalyzing asymmetric cylopropanations of heteroarenes, (2) to expand the scope of this activity to a variety of N-heterocycles, particularly those with no current asymmetric counterpart, and (3) to exploit the hydrogen- bonding network of enzymes to harness the ring-opening reactivity of the corresponding push-pull cyclopropanes. The overall goal is to develop an enzyme-controlled chemodivergent platform for the diversified synthesis of functionalized heterocycles. On a practical level, such a development would represent a powerful tool for medicinal chemists and would provide rapid and efficient access to privileged molecular frameworks in a library fashion. Fundamentally, the proposed research will expand our understanding of enzymatic cascade reactions and explore new catalytic processes that could inspire developments across all pillars of catalysis.

项目总结/文摘